122 related articles for article (PubMed ID: 9167448)
1. Synthesis and in vitro anti-HIV activity of certain 2-(1H-benzimidazol-2-ylamino)pyrimidin-4(3H)-ones and related derivatives.
Badawey el-S ; Kappe T
Arch Pharm (Weinheim); 1997 Mar; 330(3):59-62. PubMed ID: 9167448
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors.
Chimirri A; Grasso S; Monforte P; Rao A; Zappalà M; Monforte AM; Pannecouque C; Witvrouw M; Balzarini J; De Clercq E
Antivir Chem Chemother; 1999 Jul; 10(4):211-7. PubMed ID: 10480739
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anti-HIV activity of [ddN]-[ddN] dimers and benzimidazole nucleoside dimers.
Li GR; Liu J; Pan Q; Song ZB; Luo FL; Wang SR; Zhang XL; Zhou X
Chem Biodivers; 2009 Dec; 6(12):2200-8. PubMed ID: 20020452
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-hIV activity of 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2-substituted benzimidazoles.
Rao A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
Farmaco; 2002 Oct; 57(10):819-23. PubMed ID: 12420877
[TBL] [Abstract][Full Text] [Related]
5. Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1.
Gudmundsson KS; Sebahar PR; Richardson LD; Miller JF; Turner EM; Catalano JG; Spaltenstein A; Lawrence W; Thomson M; Jenkinson S
Bioorg Med Chem Lett; 2009 Sep; 19(17):5048-52. PubMed ID: 19640718
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure and in vitro anti-human immunodeficiency virus activity of novel 3-methyl-1H,3H-thiazolo[3,4-a]benzimidazoles.
Chimirri A; Grasso S; Monforte AM; Monforte P; Rao A; Zappalà M; Bruno G; Nicolò F; Pannecouque C; Witvrouw M; De Clercq E
Antivir Chem Chemother; 1998 Sep; 9(5):431-8. PubMed ID: 9875396
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
Roth T; Morningstar ML; Boyer PL; Hughes SH; Buckheit RW; Michejda CJ
J Med Chem; 1997 Dec; 40(26):4199-207. PubMed ID: 9435891
[TBL] [Abstract][Full Text] [Related]
8. Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors.
Monforte AM; Rao A; Logoteta P; Ferro S; De Luca L; Barreca ML; Iraci N; Maga G; De Clercq E; Pannecouque C; Chimirri A
Bioorg Med Chem; 2008 Aug; 16(15):7429-35. PubMed ID: 18585918
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer and anti-HIV testing of some pyrazino[1,2-a]benzimidazole derivatives.
Demirayak S; Abu Mohsen U; Cağri Karaburun A
Eur J Med Chem; 2002 Mar; 37(3):255-60. PubMed ID: 11900869
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and QSAR evaluation of 2-(substituted phenyl)-1H-benzimidazoles and [2-(substituted phenyl)-benzimidazol-1-yl]-pyridin-3-yl-methanones.
Sharma D; Narasimhan B; Kumar P; Jalbout A
Eur J Med Chem; 2009 Mar; 44(3):1119-27. PubMed ID: 18657885
[TBL] [Abstract][Full Text] [Related]
11. Anti-HIV agents. I: Synthesis and in vitro anti-HIV evaluation of novel 1H,3H-thiazolo[3,4-a]benzimidazoles.
Chimirri A; Grasso S; Monforte AM; Monforte P; Zappalà M
Farmaco; 1991 Jun; 46(6):817-23. PubMed ID: 1685321
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, physicochemical properties and antimicrobial activity of some new benzimidazole derivatives.
Ansari KF; Lal C
Eur J Med Chem; 2009 Oct; 44(10):4028-33. PubMed ID: 19482384
[TBL] [Abstract][Full Text] [Related]
13. [Design, synthesis and biologic evaluation of diarylbenzimidazole derivatives as novel HIV-1 non-nucleoside reverse transcriptase inhibitors].
Qin BJ; Zhou T; Lu H; Jiang SB; Xie L
Yao Xue Xue Bao; 2009 Nov; 44(11):1233-43. PubMed ID: 21355324
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of some novel 2-phenyl benzimidazole-1-acetamide derivatives as potential anthelmintic agents.
Sawant R; Kawade D
Acta Pharm; 2011 Sep; 61(3):353-61. PubMed ID: 21945914
[TBL] [Abstract][Full Text] [Related]
15. Computer-assisted design, synthesis and biological evaluation of novel pyrrolyl heteroaryl sulfones targeted at HIV-1 reverse transcriptase as non-nucleoside inhibitors.
Silvestri R; Artico M; De Martino G; Novellino E; Greco G; Lavecchia A; Massa S; Loi AG; Doratiotto S; La Colla P
Bioorg Med Chem; 2000 Sep; 8(9):2305-9. PubMed ID: 11026542
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
Porcari AR; Devivar RV; Kucera LS; Drach JC; Townsend LB
J Med Chem; 1998 Apr; 41(8):1252-62. PubMed ID: 9548815
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro antimicrobial and cytotoxic activities of novel pyrimidine-benzimidazol combinations.
Chen PJ; Yang A; Gu YF; Zhang XS; Shao KP; Xue DQ; He P; Jiang TF; Zhang QR; Liu HM
Bioorg Med Chem Lett; 2014 Jun; 24(12):2741-3. PubMed ID: 24798098
[TBL] [Abstract][Full Text] [Related]
18. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.
Monforte AM; Logoteta P; Ferro S; De Luca L; Iraci N; Maga G; Clercq ED; Pannecouque C; Chimirri A
Bioorg Med Chem; 2009 Aug; 17(16):5962-7. PubMed ID: 19616956
[TBL] [Abstract][Full Text] [Related]
20. Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT.
Barreca ML; Rao A; De Luca L; Zappalà M; Monforte AM; Maga G; Pannecouque C; Balzarini J; De Clercq E; Chimirri A; Monforte P
J Med Chem; 2005 May; 48(9):3433-7. PubMed ID: 15857150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
